Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Perrigo Company (PRGO)

Perrigo Company (PRGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Perrigo Company THE SHARP BUILDING HOGAN PLACE DUBLIN L2 D02 IRL

www.perrigo.com Employees: 8,379 P: 353-1709-4000

Sector:

Medical

Description:

Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International'(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.

Key Statistics

Overview:

Market Capitalization, $K 1,849,666
Enterprise Value, $K 4,908,967
Shares Outstanding, K 137,624
Annual Sales, $ 4,373 M
Annual Net Income, $ -171,800 K
Last Quarter Sales, $ 1,043 M
Last Quarter Net Income, $ 7,500 K
EBIT, $ 279,100 K
EBITDA, $ 613,900 K
60-Month Beta 0.39
% of Insider Shareholders 0.70%
% of Institutional Shareholders 95.91%
Float, K 136,661
% Float 99.30%
Short Volume Ratio 0.60

Growth:

1-Year Return -52.78%
3-Year Return -57.40%
5-Year Return -71.89%
5-Year Revenue Growth -9.59%
5-Year Earnings Growth -36.23%
5-Year Dividend Growth 34.15%

Per-Share Information:

Most Recent Earnings 0.80 on 11/05/25
Next Earnings Date N/A
Earnings Per Share ttm 2.90
EPS Growth vs. Prev Qtr 40.35%
EPS Growth vs. Prev Year -1.23%
Annual Dividend & Yield 1.16 (8.63%)
Annual Dividend & Yield (Fwd) 1.16 (8.60%)
Most Recent Dividend 0.290 on 11/28/25
Next Ex-Dividends Date 11/28/25
Dividend Payable Date 12/16/25
Dividend Payout Ratio 38.97%

PRGO Ratios

Ratio
Price/Earnings ttm 4.65
Price/Earnings forward 4.84
Price/Earnings to Growth N/A
Return-on-Equity % 9.16%
Return-on-Assets % 4.07%
Profit Margin % -3.93%
Debt/Equity 0.82
Price/Sales 0.42
Price/Cash Flow 2.67
Price/Book 0.42
Book Value/Share 32.32
Interest Coverage -0.57

PRGO Dividends

Date Value
11/28/25 $0.2900
08/29/25 $0.2900
05/30/25 $0.2900
03/07/25 $0.2900
11/29/24 $0.2760
08/30/24 $0.2760
05/31/24 $0.2760
03/07/24 $0.2760
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar